Amicus Therapeutics Inc (FOLD)
9.485
-0.10
(-1.09%)
USD |
NASDAQ |
Nov 21, 16:00
9.485
0.00 (0.00%)
After-Hours: 19:04
Amicus Therapeutics Market Cap: 2.834B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.866B |
| November 19, 2024 | 2.845B |
| November 18, 2024 | 2.886B |
| November 15, 2024 | 2.892B |
| November 14, 2024 | 3.015B |
| November 13, 2024 | 3.099B |
| November 12, 2024 | 3.134B |
| November 11, 2024 | 3.194B |
| November 08, 2024 | 3.284B |
| November 07, 2024 | 3.281B |
| November 06, 2024 | 3.359B |
| November 05, 2024 | 3.508B |
| November 04, 2024 | 3.385B |
| November 01, 2024 | 3.427B |
| October 31, 2024 | 3.412B |
| October 30, 2024 | 3.460B |
| October 29, 2024 | 3.433B |
| October 28, 2024 | 3.442B |
| October 25, 2024 | 3.493B |
| October 24, 2024 | 3.513B |
| October 23, 2024 | 3.405B |
| October 22, 2024 | 3.545B |
| October 21, 2024 | 3.587B |
| October 18, 2024 | 3.554B |
| October 17, 2024 | 3.575B |
| Date | Value |
|---|---|
| October 16, 2024 | 3.136B |
| October 15, 2024 | 3.080B |
| October 14, 2024 | 3.112B |
| October 11, 2024 | 3.136B |
| October 10, 2024 | 3.002B |
| October 09, 2024 | 3.035B |
| October 08, 2024 | 2.999B |
| October 07, 2024 | 3.053B |
| October 04, 2024 | 3.166B |
| October 03, 2024 | 3.154B |
| October 02, 2024 | 3.163B |
| October 01, 2024 | 3.184B |
| September 30, 2024 | 3.190B |
| September 27, 2024 | 3.176B |
| September 26, 2024 | 3.179B |
| September 25, 2024 | 3.227B |
| September 24, 2024 | 3.328B |
| September 23, 2024 | 3.328B |
| September 20, 2024 | 3.349B |
| September 19, 2024 | 3.262B |
| September 18, 2024 | 3.236B |
| September 17, 2024 | 3.322B |
| September 16, 2024 | 3.280B |
| September 13, 2024 | 3.351B |
| September 12, 2024 | 3.346B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.706B
Minimum
Mar 12 2020
6.486B
Maximum
Dec 22 2020
3.263B
Average
3.159B
Median
Market Cap Benchmarks
| Tonix Pharmaceuticals Holding Corp | 37.66M |
| Alnylam Pharmaceuticals Inc | 31.84B |
| Ionis Pharmaceuticals Inc | 5.360B |
| Arbutus Biopharma Corp | 655.64M |
| Krystal Biotech Inc | 5.248B |
Market Cap Related Metrics
| PS Ratio | 5.822 |
| Price to Book Value | 15.85 |
| Price | 9.485 |
| Earnings Yield | -3.58% |
| Operating PE Ratio | 199.58 |